Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Uterine Cervical Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Triple Negative Breast Neoplasms 1 Peritoneal Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Melanoma 1 HER2 Negative Breast Cancer 1 Carcinoma, Ovarian Epithelial 1

Interventions

Blood Specimen Collection 5 Liquid Biopsy 2 Folfox protocol 2 Carboplatin 2 pertuzumab 1 Trastuzumab 1 Surgical Procedures, Operative 1 Standard of Care 1 Sevoflurane 1 Radiotherapy, Adjuvant 1 Propofol 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Neoadjuvant Therapy 1 Mastectomy, Segmental 1 Gemcitabine 1 Fluorouracil 1 Epirubicin 1 Drug Therapy 1 Docetaxel 1 Cyclophosphamide 1 Colonography, Computed Tomographic 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplastic Cells, Circulating × Chemotherapy, Adjuvant × Clear all

NCT04902937 2023-11-28

CETC

University of Jena

Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡